Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Obsidian Therapeutics Appoints Lee Giguere, J.D., as Chief Legal Officer and Corporate Secretary
Obsidian Therapeutics, Inc., a biotechnology company pioneering engineered cell and gene therapies, today announced the […]
Corbus Pharmaceuticals Appoints Rachael Brake, Ph.D., as Chief Scientific Officer
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”) today announced the appointment of Rachael Brake, […]
Metrion Biosciences Expands Ion Channel Drug Discovery Service Capabilities and In-house Expertise
Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today […]
Amphista Therapeutics Appoints Dr Martin Pass as CDO
Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the […]
Equality Health Appoints Garrett E. Black as Chief Operating Officer
Equality Health, a leading provider of value-based physician networks uniquely equipped to address the needs of diverse […]
Caris Life Sciences Announces Appointment of Lloyd B. Minor to Board of Directors
Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering innovative […]
Gateway Health Names Ellen Duffield President and Chief Executive Officer
Gateway Health Plan, Inc. (“Gateway Health”) today appointed Ellen Duffield as President and Chief Executive Officer effective […]
BICO Announces Appointment of Susan Tousi as New Member of the Board of Directors
Today BICO, the world’s leading Bio Convergence company announced it has added Susan Tousi to […]
Rebeca Sanchez Sarmiento Joins Insightful Science and Dotmatics as Chief Financial Officer
Insightful Science, the world’s most widely adopted software platform for scientific R&D and collaboration, today announced […]
Coave Therapeutics Strengthens Leadership Team with the Appointments of Thomas Blaettler MD as Chief Medical Officer and Patricia Françon PhD as Chief Operating Officer
Coave Therapeutics (‘Coave‘), a clinical-stage biotechnology company focused on developing life-changing gene therapies in rare […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more